A $3.3 million study at the University of Houston College of Optometry will track the health of patients with prediabetes and diabetes to find out who might develop eye problems and be at risk for future vision loss.
Numinus Wellness’ Response to FDA’s MDMA Decision
Numinus Wellness Inc. (TSX:NUMI), a mental health care specializing in innovative treatments, recently commented on the FDA’s decision regarding Lykos Therapeutics’ new drug application for